NK Cells and Type 1 Diabetes
Type 1 diabetes (T1D) is characterized by an immuno-mediated progressive destruction of the pancreatic β cells. Due to the ability of NK cells to kill target cells as well as to interact with antigen-presenting and T cells, it has been suggested that they could be involved in one or multiple steps o...
Saved in:
| Main Authors: | Melanie Rodacki, Adolpho Milech, José Egídio Paulo de Oliveira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1080/17402520600877182 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunomodulatory agents and cell therapy for patients with type 1 diabetes
by: Melanie Rodacki, et al.
Published: (2024-12-01) -
Low-dose interleukin-2-loaded nanoparticle effect on NK and T-reg cell expression in experimentally induced type 1 diabetes mellitus
by: Salma Aboelnazar, et al.
Published: (2021-03-01) -
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors
by: Valentina Obino, et al.
Published: (2025-06-01) -
Cell-targeted PD-1 agonists are potent NK-cell inhibitors
by: Harriet C. Pope, et al.
Published: (2025-08-01) -
The Role of NK Cells in the Control of Viral Infection in HTLV-1 Carriers
by: Camila F. Amorim, et al.
Published: (2019-01-01)